Role of octreotide in the treatment of external pancreatic pure fistulas: A single-institution prospective experience

Claudio Bassi, Massimo Falconi, Roberto Salvia, Erminia Caldiron, Giovanni Butturini, Paolo Pederzoli

Research output: Contribution to journalArticle

Abstract

Introduction: Octreotide was studied in the treatment of pure external pancreatic fistulas. Methods: Eighteen cases (12 males, 6 females) were prospectively observed. Six patients (four after radical surgery for periampullary cancer, one endocrine tumor enucleation and one pancreojejunostomy in chronic pancreatitis) were treated as outpatients with octreotide alone because of low basal fistula output (mean±SD: 96.6±27.4 cc/24 h). Twelve (five radical surgery for cancer, five surgery for severe pancreatitis, one enucleation and one pancreojejunostomy) were treated as inpatients with octreotide plus total parenteral nutrition because of the high output (mean±SD: 448.4±248.2 cc/24 h). Results: Ten of the 12 high- output fistulas healed in 27.8±27.7 days, whereas all low-output fistulas healed in 12.1 ± 6.6 days. Conclusion: Octreotide appears useful in the treatment of external pancreatic fistulas. For optimal results to be achieved, there must be no local infection and no mechanical or anatomical obstacles to the free flow of juice.

Original languageEnglish
Pages (from-to)10-13
Number of pages4
JournalLangenbeck's Archives of Surgery
Volume385
Issue number1
Publication statusPublished - Jan 2000

Fingerprint

Cutaneous Fistula
Pancreatic Fistula
Octreotide
Fistula
Endocrine Gland Neoplasms
Total Parenteral Nutrition
Chronic Pancreatitis
Therapeutics
Pancreatitis
Inpatients
Neoplasms
Outpatients
Infection

Keywords

  • External pancreatic fistulas
  • Octreotide
  • Pancreatic cancer
  • Pancreatic surgery
  • Pancreatitis

ASJC Scopus subject areas

  • Surgery

Cite this

Role of octreotide in the treatment of external pancreatic pure fistulas : A single-institution prospective experience. / Bassi, Claudio; Falconi, Massimo; Salvia, Roberto; Caldiron, Erminia; Butturini, Giovanni; Pederzoli, Paolo.

In: Langenbeck's Archives of Surgery, Vol. 385, No. 1, 01.2000, p. 10-13.

Research output: Contribution to journalArticle

Bassi, Claudio ; Falconi, Massimo ; Salvia, Roberto ; Caldiron, Erminia ; Butturini, Giovanni ; Pederzoli, Paolo. / Role of octreotide in the treatment of external pancreatic pure fistulas : A single-institution prospective experience. In: Langenbeck's Archives of Surgery. 2000 ; Vol. 385, No. 1. pp. 10-13.
@article{8a2caa328b054050ad72fab725daf95a,
title = "Role of octreotide in the treatment of external pancreatic pure fistulas: A single-institution prospective experience",
abstract = "Introduction: Octreotide was studied in the treatment of pure external pancreatic fistulas. Methods: Eighteen cases (12 males, 6 females) were prospectively observed. Six patients (four after radical surgery for periampullary cancer, one endocrine tumor enucleation and one pancreojejunostomy in chronic pancreatitis) were treated as outpatients with octreotide alone because of low basal fistula output (mean±SD: 96.6±27.4 cc/24 h). Twelve (five radical surgery for cancer, five surgery for severe pancreatitis, one enucleation and one pancreojejunostomy) were treated as inpatients with octreotide plus total parenteral nutrition because of the high output (mean±SD: 448.4±248.2 cc/24 h). Results: Ten of the 12 high- output fistulas healed in 27.8±27.7 days, whereas all low-output fistulas healed in 12.1 ± 6.6 days. Conclusion: Octreotide appears useful in the treatment of external pancreatic fistulas. For optimal results to be achieved, there must be no local infection and no mechanical or anatomical obstacles to the free flow of juice.",
keywords = "External pancreatic fistulas, Octreotide, Pancreatic cancer, Pancreatic surgery, Pancreatitis",
author = "Claudio Bassi and Massimo Falconi and Roberto Salvia and Erminia Caldiron and Giovanni Butturini and Paolo Pederzoli",
year = "2000",
month = "1",
language = "English",
volume = "385",
pages = "10--13",
journal = "Langenbecks Archiv fur Chirurgie",
issn = "0023-8236",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Role of octreotide in the treatment of external pancreatic pure fistulas

T2 - A single-institution prospective experience

AU - Bassi, Claudio

AU - Falconi, Massimo

AU - Salvia, Roberto

AU - Caldiron, Erminia

AU - Butturini, Giovanni

AU - Pederzoli, Paolo

PY - 2000/1

Y1 - 2000/1

N2 - Introduction: Octreotide was studied in the treatment of pure external pancreatic fistulas. Methods: Eighteen cases (12 males, 6 females) were prospectively observed. Six patients (four after radical surgery for periampullary cancer, one endocrine tumor enucleation and one pancreojejunostomy in chronic pancreatitis) were treated as outpatients with octreotide alone because of low basal fistula output (mean±SD: 96.6±27.4 cc/24 h). Twelve (five radical surgery for cancer, five surgery for severe pancreatitis, one enucleation and one pancreojejunostomy) were treated as inpatients with octreotide plus total parenteral nutrition because of the high output (mean±SD: 448.4±248.2 cc/24 h). Results: Ten of the 12 high- output fistulas healed in 27.8±27.7 days, whereas all low-output fistulas healed in 12.1 ± 6.6 days. Conclusion: Octreotide appears useful in the treatment of external pancreatic fistulas. For optimal results to be achieved, there must be no local infection and no mechanical or anatomical obstacles to the free flow of juice.

AB - Introduction: Octreotide was studied in the treatment of pure external pancreatic fistulas. Methods: Eighteen cases (12 males, 6 females) were prospectively observed. Six patients (four after radical surgery for periampullary cancer, one endocrine tumor enucleation and one pancreojejunostomy in chronic pancreatitis) were treated as outpatients with octreotide alone because of low basal fistula output (mean±SD: 96.6±27.4 cc/24 h). Twelve (five radical surgery for cancer, five surgery for severe pancreatitis, one enucleation and one pancreojejunostomy) were treated as inpatients with octreotide plus total parenteral nutrition because of the high output (mean±SD: 448.4±248.2 cc/24 h). Results: Ten of the 12 high- output fistulas healed in 27.8±27.7 days, whereas all low-output fistulas healed in 12.1 ± 6.6 days. Conclusion: Octreotide appears useful in the treatment of external pancreatic fistulas. For optimal results to be achieved, there must be no local infection and no mechanical or anatomical obstacles to the free flow of juice.

KW - External pancreatic fistulas

KW - Octreotide

KW - Pancreatic cancer

KW - Pancreatic surgery

KW - Pancreatitis

UR - http://www.scopus.com/inward/record.url?scp=0034024535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034024535&partnerID=8YFLogxK

M3 - Article

C2 - 10664113

AN - SCOPUS:0034024535

VL - 385

SP - 10

EP - 13

JO - Langenbecks Archiv fur Chirurgie

JF - Langenbecks Archiv fur Chirurgie

SN - 0023-8236

IS - 1

ER -